Abstract:Objective: To investigate the effect of continuous veno-venous hemofiltration (CVVH) in the treatment of acute severe hyponatremia. Methods: Six patients with acute severe hyponatremia were studied, including 5 males and 1 female, aged 48.5 (25 - 61) years. Clinical manifestations of hyponatremia included confusion (6/6), drowsiness (3/6), and delirium (3/6). The course of hyponatremia before the initiation of CVVH was 45 - 48 hours. AN69, AV600, FH66 and HF1200 hemofilters were applied and changed every 24 hours. The ultrafiltration rate was 2 000 ml/h, with a blood flow rate of 200 - 250 ml/min, and the substitute fluid was infused by a pre-dilution route. Low molecular weight heparin was used for anticoagulation. Results: The average treatment duration of CVVH was 59.7 (45.6 - 86) hours. All the patients survived and tolerated CVVH well. During CVVH, the serum sodium increased significantly from (101.2 +/- 4.2) mmol/L before CVVH, to (115.0 +/- 2.7) mmol/L at the 6th hour of CVVH, (129.2 +/- 4.1) mmol/L at the 24th hour, and (140.3 +/- 1.6) mmol/L at the 48th hour of CVVH; with the correction rate of serum sodium controlled at (2.5 +/- 0.4) mmol.L(-1).h(-1) over the first 24 hours, (1.2 +/- 0.1) mmol.L(-1).h(-1) for the first 48th hour, and the correction rate of (0.82 +/- 0.10) mmol.L(-1).h(-1). The sodium concentrations in the replacement solution were (16.0 +/- 6.0) mmol/L higher than the serum sodium concentration at 0 hour, (11.6 +/- 4.3) mmol/L higher at 4th hour, (5.5 +/- 5.1) mmol/L higher at 24th hour, and (0.75 +/- 0.96) mmol/L higher at 48th hour of CVVH. After CVVH, the serum osmolarity increased significantly, from (216.7 +/- 7.4) mOsm/kgH(2)O pre-CVVH, to (245.0 +/- 5.5) mOsm/kgH(2)O at 6th hour, with a correction rate of (5.16 +/- 0.81) mOsm.kgH(2)O(-1).h(-1); (272.7 +/- 7.1) mOsm/kgH(2)O at 24th hour, with a correction rate of (2.33 +/- 0.28) mOsm.kgH(2)O(-1).h(-1); and (295.0 +/- 4.2) mOsm/kgH(2)O at 48th hour, with a correction rate of (1.63 +/- 0.20) mOsm.kgH(2)O(-1).h(-1). The Glasgow scores and APACHEII scores improved significantly as compared to pretreatment. Conclusion: CVVH is effective in the treatment of acute severe hyponatremia, and could be considered as a treatment option because of its slow and continuous nature. A low-sodium replacement solution should be prepared to minimize its sodium concentration difference from the serum concentration. We recommend that the serum sodium concentration be corrected at an average rate of (2.50 +/- 0.14) mmol.L(-1).h(-1) at 6 h, (1.2 +/- 0.1) mmol.L(-1).h(-1) at 24 h and (0.82 +/- 0.10) mmol.L(-1).h(-1) at 48 h.

Comparison of the effects between continuous veno-venous hemofiltration and hemodialysis on patients with uremic encephalopathy

Application of Continuous Veno-Venous Hemodiafiltration to Severely Acute Renal Failure after Cardiac Surgery

Clinical Study of the Influence of Continuous Hemofiltration on Gastrointestinal Dysfunction of the Patients with Intra-Abdominal Hypertension

The effect of continuous renal replacement therapy in patients with acute kidney injury on the serum levels of urea,creatinine and cystatin C

Comparative Analysis of Efficacy and Prognosis of Hemodialysis and Peritoneal Dialysis for End-Stage Renal Disease: A Meta-analysis.

Effect of the Application of Continuous Cenous Venous Hemofiltration on Pulmonary Vascular Permeability in the Early Stage of Septic Shock

Clinical Analysis of Continuous Venovenous Hemofiltration in Patients with Severe Congestive Heart Failure

Clinlic Study of Continuous Venovenous Hemofiltration in Treatment of Hepatorenal Syndrome

Nursing Care of Continuous Veno-Venous Hemofiltration for Patients with Hepatorenal Syndrome

MO633: Survival Comparison Between CVVHDF and CVVH for Septic Acute Kidney Injury

The Effect of Substitution Fluid Rate on the Prognosis of Critical Acute Kidney Injury Patients Treated with Continuous Veno-Venous Hemorfltration Therapy

COMPARATIVE STUDY OF SOLUTES CLEARANCES BETWEEN VARIOUS CONTINUOUS RENAL REPLACEMENT THERAPY METHODS

Continuous Venovenous Hemofi Ltration with Citrate Based,calcium-,Mag Nesium-Free Replacement Solution in Acut E Renal Failure Patients at High Risk of Bleeding

Primary Clinical Experience in High Risk Uremic Patients Converted from Conventional to Short Daily Hemodialysis

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Comparison of Therapeutic Efficiency Between Saccharum Iron and Ferrum Dextran Iron: a Multicenter Clinical Trial

Continuous Veno-Venous Hemofiltration in Treatment of Acute Severe Hyponatremia:A Report of 6 Cases

Effects of Continuous Veno-Venous Hemofiltration in Gerontal Patients with Multiple Organ Failure

Influence of continous veno-venous hemofiltration therapy on PiCCO monitering data

The Influence of Different Blood Purification Methods on Anemia of Uremic Patients

[Continuous veno-venous hemofiltration in treatment of acute severe hyponatremia: a report of 6 cases]